// App-Quantinova.ai

21 : The mTORC2 target Akt is regulated in response to glutamine metabolite levels

Researchers

Presenter

  • Estela Jacinto

Principal Investigators

  • Joseph Moloughney

  • Peter K. Kim

  • Nicole M. Vega-Cotto

  • Chang-Chih Wu

  • Thomas Lynch

  • Sisi Zhang

  • Matthew Adlam

  • Sai Guntaka

  • Po-Chien Chou

  • Joshua D. Rabinowitz

  • Guy Werlen

Medical Centers

  • Rutgers-RWJ Medical School, Piscataway, NJ

  • Princeton University, Princeton, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Heparin-binding protein

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Glutamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved